Related references
Note: Only part of the references are listed.Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures
Matthew Austin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)
Richard M. Jacques et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Does osteoporosis therapy invalidate FRAX for fracture prediction?
William D. Leslie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Bone-Density Testing Interval and Transition to Osteoporosis in Older Women
Margaret L. Gourlay et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Treatment failure in osteoporosis
A. Diez-Perez et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Bone Density Testing Intervals and Common Sense
E. Michael Lewiecki et al.
CURRENT OSTEOPOROSIS REPORTS (2012)
Effects of Antiresorptive Treatment on Nonvertebral Fracture Outcomes
Dawn C. Mackey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
S. Vasikaran et al.
OSTEOPOROSIS INTERNATIONAL (2011)
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2-therapy
Daniel G. Hackam et al.
CANADIAN JOURNAL OF CARDIOLOGY (2010)
Efficacy of Continued Alendronate for Fractures in Women With and Without Prevalent Vertebral Fracture: The FLEX Trial
Ann V. Schwartz et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Hip Fracture Patients at Risk of Second Hip Fracture: A Nationwide Population-Based Cohort Study of 169,145 Cases During 1977-2001
Peter Ryg et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Bone turnover markers: understanding their value in clinical trials and clinical practice
R. Civitelli et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Monitoring osteoporosis therapy: Bone mineral density, bone turnover markers, or both?
SL Bonnick et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: Reduction in risk of nonvertebral fracture is not related to change in BMD
NB Watts et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial
RD Chapurlat et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs
SR Cummings et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy
S Sarkar et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Risk of new vertebral fracture in the year following a fracture
R Lindsay et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
